Amoxicillin Sodium Clavulanate Potassium for Injection Market Report – Research, Industry Analysis Reports and Market Demands

Global Amoxicillin Sodium Clavulanate Potassium for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 0.3g
- 1.3.3 0.6g
- 1.3.4 1.2g
- 1.3.5 2.4g and Other Strengths
1.4 Market Analysis by Active-ingredient Ratio
- 1.4.1 Overview: Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Active-ingredient Ratio: 2021 Versus 2025 Versus 2032
- 1.4.2 Amoxicillin/Clavulanate 5:1
- 1.4.3 Amoxicillin/Clavulanate 10:1
- 1.4.4 Other Approved Ratios
1.5 Market Analysis by Patient Group
- 1.5.1 Overview: Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Patient Group: 2021 Versus 2025 Versus 2032
- 1.5.2 Adult Products
- 1.5.3 Pediatric and Low-dose Products
- 1.5.4 General-purpose Products
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 General Hospitals
- 1.6.3 Emergency and Critical Care
- 1.6.4 Surgical and Perioperative Care
- 1.6.5 Pediatric Medical Institutions
- 1.6.6 Other Medical Institutions
1.7 Global Amoxicillin Sodium Clavulanate Potassium for Injection Market Size & Forecast
- 1.7.1 Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity (2021-2032)
- 1.7.3 Global Amoxicillin Sodium Clavulanate Potassium for Injection Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Amoxicillin Sodium Clavulanate Potassium for Injection by Manufacturer

3.1 Global Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Amoxicillin Sodium Clavulanate Potassium for Injection Revenue by Manufacturer (2021-2026)
3.3 Global Amoxicillin Sodium Clavulanate Potassium for Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Amoxicillin Sodium Clavulanate Potassium for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Amoxicillin Sodium Clavulanate Potassium for Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Amoxicillin Sodium Clavulanate Potassium for Injection Manufacturer Market Share in 2025
3.5 Amoxicillin Sodium Clavulanate Potassium for Injection Market: Overall Company Footprint Analysis
- 3.5.1 Amoxicillin Sodium Clavulanate Potassium for Injection Market: Region Footprint
- 3.5.2 Amoxicillin Sodium Clavulanate Potassium for Injection Market: Company Product Type Footprint
- 3.5.3 Amoxicillin Sodium Clavulanate Potassium for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Amoxicillin Sodium Clavulanate Potassium for Injection Market Size by Region
- 4.1.1 Global Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Amoxicillin Sodium Clavulanate Potassium for Injection Average Price by Region (2021-2032)
4.2 North America Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value (2021-2032)
4.3 Europe Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value (2021-2032)
4.5 South America Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Type (2021-2032)
5.2 Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Type (2021-2032)
5.3 Global Amoxicillin Sodium Clavulanate Potassium for Injection Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Application (2021-2032)
6.2 Global Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Application (2021-2032)
6.3 Global Amoxicillin Sodium Clavulanate Potassium for Injection Average Price by Application (2021-2032)

7 North America

7.1 North America Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Type (2021-2032)
7.2 North America Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Application (2021-2032)
7.3 North America Amoxicillin Sodium Clavulanate Potassium for Injection Market Size by Country
- 7.3.1 North America Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Type (2021-2032)
8.2 Europe Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Application (2021-2032)
8.3 Europe Amoxicillin Sodium Clavulanate Potassium for Injection Market Size by Country
- 8.3.1 Europe Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Amoxicillin Sodium Clavulanate Potassium for Injection Market Size by Region
- 9.3.1 Asia-Pacific Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Type (2021-2032)
10.2 South America Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Application (2021-2032)
10.3 South America Amoxicillin Sodium Clavulanate Potassium for Injection Market Size by Country
- 10.3.1 South America Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Amoxicillin Sodium Clavulanate Potassium for Injection Market Size by Country
- 11.3.1 Middle East & Africa Amoxicillin Sodium Clavulanate Potassium for Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Amoxicillin Sodium Clavulanate Potassium for Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Amoxicillin Sodium Clavulanate Potassium for Injection Market Drivers
12.2 Amoxicillin Sodium Clavulanate Potassium for Injection Market Restraints
12.3 Amoxicillin Sodium Clavulanate Potassium for Injection Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Amoxicillin Sodium Clavulanate Potassium for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Amoxicillin Sodium Clavulanate Potassium for Injection
13.3 Amoxicillin Sodium Clavulanate Potassium for Injection Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Amoxicillin Sodium Clavulanate Potassium for Injection Typical Distributors
14.3 Amoxicillin Sodium Clavulanate Potassium for Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Amoxicillin Sodium Clavulanate Potassium for Injection market size was valued at US$ 1235 million in 2025 and is forecast to a readjusted size of US$ 1787 million by 2032 with a CAGR of 5.1% during review period.
Amoxicillin Sodium Clavulanate Potassium for Injection is a sterile powder formulation containing amoxicillin in the form of amoxicillin sodium and clavulanic acid in the form of potassium clavulanate.
The product is reconstituted before use and administered by intravenous injection or intravenous infusion. The conventional formulation normally contains amoxicillin and clavulanic acid at a 5:1 ratio, including 500mg/100mg and 1,000mg/200mg presentations. Approved 10:1 and other ratio products may also be included.
The scope covers finished sterile vials supplied to hospitals and other medical institutions. Oral formulations, standalone APIs, compound APIs, diluents and hospital administration services are excluded.
The 2025 ASP is US$3.20 per vial, global sales volume is approximately 375.00 million vials, and the estimated average gross margin is approximately 31%.
The upstream chain includes sterile amoxicillin sodium, sterile potassium clavulanate, pharmaceutical glass vials, rubber stoppers, aluminum seals, nitrogen, desiccants and pharmaceutical packaging materials. Midstream activities include sterile raw-material testing, low-humidity blending, aseptic filling, nitrogen protection, stoppering, capping, sterility testing, bacterial-endotoxin testing and batch release. Downstream users mainly include general hospitals, emergency departments, intensive-care units, surgical departments, pediatric hospitals and other medical institutions.
Global demand is primarily generated by hospitals treating moderate and severe bacterial infections where oral administration is unsuitable, rapid drug exposure is required or patients cannot tolerate oral medicines.
The 0.6g and 1.2g presentations remain the principal commercial specifications. The 1.2g vial is widely used for adults, while lower-strength products provide more flexible dosing for children, low-body-weight patients and patients requiring dose adjustment.
The conventional 5:1 formulation remains the dominant product structure. Higher amoxicillin-to-clavulanate ratios are being developed in selected markets to reduce clavulanate exposure while maintaining the required amoxicillin dose.
Manufacturing barriers are higher than for oral tablets and suspensions. Production requires sterile beta-lactam facilities, strict segregation, low-humidity handling, validated mixing uniformity and rapid filling because both active ingredients are sensitive to moisture and processing conditions.
Government tenders and hospital purchasing alliances have increased price pressure on standard generic products. Manufacturers are responding by improving batch size, filling-line utilization, yield and packaging efficiency.
Supply reliability is becoming increasingly important. Hospitals and procurement authorities are more willing to qualify multiple suppliers because sterile injectable shortages can immediately affect clinical treatment.
Quality competition is shifting toward sterility assurance, particulate control, moisture control, stability after reconstitution and consistency between batches. Registration status and reference-product comparability are becoming as important as nominal formulation strength.
Asia-Pacific represents the largest manufacturing and consumption region, supported by China and India. Europe remains an important production and regulated-market supply base, while the Middle East, Africa and Southeast Asia continue to depend partly on imported products.
Antimicrobial-stewardship policies will restrain unnecessary consumption. Future market growth will therefore mainly come from improved access to hospital care, population growth, increasing hospital admissions and replacement of unregistered or lower-quality supply rather than from indiscriminate antibiotic use.
Report Scope
This report is a detailed and comprehensive analysis for global Amoxicillin Sodium Clavulanate Potassium for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Amoxicillin Sodium Clavulanate Potassium for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (US$/Vial), 2021-2032
Global Amoxicillin Sodium Clavulanate Potassium for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (US$/Vial), 2021-2032
Global Amoxicillin Sodium Clavulanate Potassium for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (US$/Vial), 2021-2032
Global Amoxicillin Sodium Clavulanate Potassium for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (US$/Vial), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Amoxicillin Sodium Clavulanate Potassium for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Amoxicillin Sodium Clavulanate Potassium for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Sandoz, Sun Pharmaceutical Industries Ltd., Antibiotice S.A., Chengdu Brilliant Pharmaceutical Co., Ltd., Zhuhai United Laboratories Co., Ltd., Sinopharm Weiqida Pharmaceutical Co., Ltd., NCPC Xiantai Pharmaceutical Co., Ltd., Reyoung Pharmaceutical Co., Ltd., Hunan Kelun Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Amoxicillin Sodium Clavulanate Potassium for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
0.3g
0.6g
1.2g
2.4g and Other Strengths
Market segment by Active-ingredient Ratio
Amoxicillin/Clavulanate 5:1
Amoxicillin/Clavulanate 10:1
Other Approved Ratios
Market segment by Patient Group
Adult Products
Pediatric and Low-dose Products
General-purpose Products
Market segment by Application
General Hospitals
Emergency and Critical Care
Surgical and Perioperative Care
Pediatric Medical Institutions
Other Medical Institutions
Major players covered
GSK
Sandoz
Sun Pharmaceutical Industries Ltd.
Antibiotice S.A.
Chengdu Brilliant Pharmaceutical Co., Ltd.
Zhuhai United Laboratories Co., Ltd.
Sinopharm Weiqida Pharmaceutical Co., Ltd.
NCPC Xiantai Pharmaceutical Co., Ltd.
Reyoung Pharmaceutical Co., Ltd.
Hunan Kelun Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Shandong Erye Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Hainan Hailing Chemipharma Corporation Limited
Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.
Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Tianjin Huajin Pharmaceutical Co., Ltd.
Shanghai SPH New Asia Pharmaceutical Co., Ltd.
Jiangxi Dongfeng Pharmaceutical Co., Ltd.
Haikou Qili Pharmaceutical Co., Ltd.
Youcare Pharmaceutical Group Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Amoxicillin Sodium Clavulanate Potassium for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Amoxicillin Sodium Clavulanate Potassium for Injection, with price, sales quantity, revenue, and global market share of Amoxicillin Sodium Clavulanate Potassium for Injection from 2021 to 2026.
Chapter 3, the Amoxicillin Sodium Clavulanate Potassium for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amoxicillin Sodium Clavulanate Potassium for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Amoxicillin Sodium Clavulanate Potassium for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Amoxicillin Sodium Clavulanate Potassium for Injection.
Chapter 14 and 15, to describe Amoxicillin Sodium Clavulanate Potassium for Injection sales channel, distributors, customers, research findings and conclusion.

Buy now